Skip to Content

Drug interactions between Lessina and Orsythia

Results for the following 2 drugs:
Lessina (ethinyl estradiol/levonorgestrel)
Orsythia (ethinyl estradiol/levonorgestrel)

Interactions between your drugs

There were no interactions found in our database between Lessina and Orsythia - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Lessina

A total of 596 drugs (2842 brand and generic names) are known to interact with Lessina.

Orsythia

A total of 596 drugs (2842 brand and generic names) are known to interact with Orsythia.

Drug and food interactions

Moderate

levonorgestrel food

Applies to: Lessina (ethinyl estradiol / levonorgestrel) and Orsythia (ethinyl estradiol / levonorgestrel)

Consumer information for this interaction is not currently available.

MONITOR: Grapefruit juice may increase the plasma concentrations of orally administered drugs that are substrates of the CYP450 3A4 isoenzyme. However, the interaction seems to affect primarily those drugs that undergo significant presystemic metabolism by CYP450 3A4 (i.e., drugs with low oral bioavailability), presumably due to the fact that grapefruit juice inhibits primarily intestinal rather than hepatic CYP450 3A4. Because pharmacokinetic interactions involving grapefruit juice are often subject to a high degree of interpatient variability, the extent to which a given patient may be affected is difficult to predict.

MANAGEMENT: Patients who regularly consume grapefruit or grapefruit juice should be monitored for adverse effects and altered plasma concentrations of drugs that undergo significant presystemic metabolism by CYP450 3A4. Grapefruit and grapefruit juice should be avoided if an interaction is suspected. Orange juice is not expected to interact with these drugs.

Minor

ethinyl estradiol food

Applies to: Lessina (ethinyl estradiol / levonorgestrel) and Orsythia (ethinyl estradiol / levonorgestrel)

Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.

For clinical details see professional interaction data.

Therapeutic duplication warnings

Therapeutic duplication is the use of more than one medicine from the same drug category or therapeutic class to treat the same condition. This can be intentional in cases where drugs with similar actions are used together for demonstrated therapeutic benefit. It can also be unintentional in cases where a patient has been treated by more than one doctor, or had prescriptions filled at more than one pharmacy, and can have potentially adverse consequences.

Duplication

Estrogens

Therapeutic duplication

The recommended maximum number of medicines in the 'estrogens' category to be taken concurrently is usually one. Your list includes one medicines belonging to the 'estrogens' category:

  • ethinyl estradiol/levonorgestrel
  • ethinyl estradiol/levonorgestrel

Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.

Duplication

Progestins

Therapeutic duplication

The recommended maximum number of medicines in the 'progestins' category to be taken concurrently is usually one. Your list includes one medicines belonging to the 'progestins' category:

  • ethinyl estradiol/levonorgestrel
  • ethinyl estradiol/levonorgestrel

Note: The benefits of taking this combination of medicines may outweigh any risks associated with therapeutic duplication. This information does not take the place of talking to your doctor. Always check with your healthcare provider to determine if any adjustments to your medications are needed.

Drug Interaction Classification

The classifications below are a guideline only. The relevance of a particular drug interaction to a specific patient is difficult to determine using this tool alone given the large number of variables that may apply.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide